Modern medical technology is evidently held in high esteem by the general population. In a recent survey conducted by the market research institute Emnid commissioned by the industry association SPECTARIS, about 80% of the patients surveyed said that under certain circumstances they would be willing to pay more for their health insurance in return for consistent treatment with state-of-the-art and innovative medical technology. In spite of the existing cost pressures, in particular in the primary (public) health care market, it is thus safe to assume that there is still a high level of interest in advanced diagnostic procedures and therapies amongst medical users and their patients.
↧